The New York Times, April 17, 2013
A jury in Chicago rejected claims on Tuesday that the orthopedics unit of Johnson & Johnson inappropriately marketed an artificial hip, which the company recalled in 2010. The verdict came in the second trial of some 10,000 pending lawsuits involving the all-metal device, which was known as the Articular Surface Replacement, or A.S.R. In March, a jury in Los Angeles awarded $8.3 million in the first trial of an A.S.R.-related case. The DePuy Orthopaedics unit of Johnson & Johnson said in a statement that all its actions related to the sale, marketing and recall of the device had been appropriate.